Viatris (VTRS) FCF Margin (2019 - 2026)
Viatris (VTRS) posted FCF Margin of 8.76% for Q2 2026, down 11.6% on a QoQ basis from 9.91% in Q1 2026, and up 410.0% year-over-year from 1.72% in Q2 2025.
Powered by 
Analysis
Viatris (VTRS) FCF Margin (2019 - 2026) Analysis & Trends
Viatris has reported FCF Margin for 8 years, with the latest figure at 8.76% in Q2 2026.
- On a quarterly basis, FCF Margin rose 410.0% year-over-year to 8.76% in Q2 2026; TTM through Jun 2026 was 13.26%, a 86.0% increase from a year earlier, with the FY2025 full-year figure at 13.55%, up 13.0% from the prior year.
- FCF Margin was 8.76% for Q2 2026 at Viatris, down from 9.91% in the prior quarter.
- The five-year high for FCF Margin was 25.62% in Q1 2022, with the low at 0.91% in Q4 2022.
- Average FCF Margin over 5 years is 14.15%, with a median of 15.28% recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: FCF Margin surged 959 bps in 2023, then slumped 934 bps in 2024.
- Over 5 years, FCF Margin stood at 0.91% in 2022, then surged by 1053 bps to 10.5% in 2023, then slipped by 8 bps to 9.7% in 2024, then surged by 72 bps to 16.72% in 2025, then slumped by 48 bps to 8.76% in 2026.
- The last three FCF Margin figures came in at 8.76% (Q2 2026), 9.91% (Q1 2026), and 16.72% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 20.79% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 14.76% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 20.15% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.76% |
| Mar 31, 2026 | 9.91% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | 17.50% |
| Jun 30, 2025 | 4.66% |
| Mar 31, 2025 | 15.15% |
| Dec 31, 2024 | 9.70% |
| Sep 30, 2024 | 19.98% |
| Jun 30, 2024 | 8.44% |
| Mar 31, 2024 | 15.42% |
| Dec 31, 2023 | 10.50% |
| Sep 30, 2023 | 18.75% |
| Jun 30, 2023 | 11.67% |
| Mar 31, 2023 | 24.76% |
| Dec 31, 2022 | 0.91% |
| Sep 30, 2022 | 18.76% |
| Jun 30, 2022 | 17.46% |
| Mar 31, 2022 | 25.62% |
| Dec 31, 2021 | 7.50% |
| Sep 30, 2021 | 21.26% |